Navigation Links
Bayer's Discrimination Lawsuit Now Requires Extra-Strength Cure
Date:5/25/2011

NEWARK, N.J., May 25, 2011 /PRNewswire/ -- Just days after the one year anniversary of winning a $250 million verdict for female sales representatives at Novartis Pharmaceuticals Corporation, the law firm of Sanford Wittels & Heisler LLP filed a nearly identical class action on behalf of female sales representatives at Bayer HealthCare Pharmaceuticals.  

According to the amended complaint, there is an entirely new class of plaintiffs and an additional Bayer HealthCare Division now added to the case.  In addition, the complaint details even more outrageous behaviors from senior Bayer individuals, including a Senior Counsel for the Company harassing women at Bayer HealthCare Corporate Care by making comments such as "I really like how you look on all fours," and telling another woman he wished he could watch an entire donut "slide down her throat."  

The female pharmaceutical sales representatives at Bayer newly added to the class have been paid and promoted less than their male counterparts.  For example, Class Representative Natalie Celske is a high-performing sales representative who has been with Bayer for thirteen years and has repeatedly won national awards for her performance.  However, Ms. Celske has watched less-qualified male counterparts pass her by as they were promoted up the ladder.  

When Ms. Celske raised questions about the lack of advancement opportunities, her male manager commented that opportunities were set aside to support a lower-performing male colleague's career development.  When she asked what about her own career development, the male manager derisively scoffed "what about it?"  

Katherine Kimpel, lead counsel for the plaintiffs and the class and partner at Sanford Wittels & Heisler, LLP, commented "Bayer's failure to recognize, promote, and otherwise treat Ms. Celske fairly is illegal.  It is also unwise; even by Bayer's own metrics, Ms. Celske is an exemplary performer.  What happened to Ms. Celske is representative of a deeper company-wide problem of gender discrimination in the sales force."

Further echoing some of the most compelling testimony in the Novartis gender discrimination case, the case has also grown to include evidence of sexual harassment ignored and tacitly condoned by Bayer.  In the Novartis trial, the jury heard compelling testimony from women who had been harassed by doctors to whom they marketed drugs.  Here, the harassers are actually on Bayer payroll.  For example, Class Representative Vera Santangelo suffered discrimination at the hands of an attorney working as Senior Counsel for Bayer HealthCare's Consumer Care division.  

"Ms. Santangelo sought help within the company in every way possible – she called the hotline, spoke with the Ombudsman, and otherwise reached out to Human Resources, the Vice President and Assistant General Counsel, and to both the former and the current Presidents of Bayer HealthCare Consumer Care," explained Steven Wittels, also an attorney for the plaintiffs and class and a founding partner at the firm.  "Rather than addressing the problem, Bayer turned a blind eye to Ms. Santangelo's plight.  Even worse, Bayer has recently been subjected Ms. Santangelo to retaliation for trying to protect her rights in the workplace."

The Amended Complaint adds two new Class Representatives -- a sales representative and an employee at Consumer Care -- to join the six Class Representatives who filed the original complaint in March of this year on behalf of themselves and a class of female managers in the United States under Title VII of the 1964 Civil Rights Act and New Jersey law on March 21, 2011.  The Amended Complaint expands the class to include all women sales representatives at Bayer HealthCare Pharmaceuticals and now all women at Bayer HealthCare Consumer Care, a division of Bayer HealthCare which was not named in the original complaint.

Ms. Kimpel commented that "if history is to be any guide, the stories of our plaintiffs are only the tip of the iceberg and can only mean more trouble for Bayer.  Bayer is supposed to be a major proponent of women's health, but there is nothing healthy about working at Bayer if you're a woman.  Sooner or later, Bayer is going to be held accountable for the ways it has mistreated, underpaid, and under-promoted its female employees."

Bayer HealthCare Pharmaceuticals and Bayer HealthCare Consumer Care are subsidiaries of Bayer Corporation, the American arm of Bayer AG, a multinational entity based in Germany.  In North America, Bayer Corporation had 2010 net sales of $10.86 billion and employed 16,400 individuals at year-end.  Bayer Corporation is incorporated under the laws of Indiana and headquartered in Pittsburgh, Pennsylvania.  Bayer HealthCare Pharmaceuticals is a subsidiary of Bayer Corporation that develops and markets prescription medications, biological products, and biotechnology.  It is incorporated under the laws of Delaware and headquartered in Wayne, New Jersey.  Bayer HealthCare Consumer Care is a subsidiary of Bayer Corporation that develops and markets over-the-counter medications and nutritional supplements.  It is incorporated under the laws of Indiana and headquartered in Morristown, New Jersey.

About Sanford Wittels & Heisler LLP

Sanford Wittels & Heisler LLP (SWH) is a boutique class-action litigation law firm with offices in New York, Washington, D.C., and San Francisco. SWH specializes in civil rights and general public interest cases, representing plaintiffs with employment discrimination, labor and wage violations, predatory lending, whistleblower, consumer fraud, and other claims. Along with an expertise in class actions, SWH also represents select individuals and has developed a particular expertise in the representation of executives in employment disputes.  For more information, visit www.swhlegal.com.

For more information, contact Jamie Moss, newsPRos, 201-493-1027, jamie@newspros.com


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
2. Plaintiffs and Novartis Pharmaceuticals Corporation, a US Subsidiary of Novartis AG, Agree to Resolve All Gender Discrimination Claims Associated With Class Action
3. DOAR Provides Trial Consulting Services in Victory for 5,600 Women in Gender Discrimination Class Action Trial Against Pharmaceutical Giant
4. Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart
5. Lilly Provides Its Perspective in Response to Amylin Lawsuit
6. Lilly Provides Statement in Response to Amylin Lawsuit
7. Par Pharmaceutical Companies Announces Settlement in Principle Regarding Certain Drug Pricing Lawsuits
8. Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division
9. Recalled DePuy Hip Implant Lawsuits Filed in Fort Worth, Texas
10. Avandia Lawsuit Settlement News: No News is Bad News, Says Plaintiffs
11. Bilateral DePuy Hip Implant Failures Lead to Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
(Date:7/5/2017)... England , July 5, 2017 Wolfmet ... perfect answer as physics and manufacturing combine to progress molecular ... thyroid, existing SPECT systems are unable to accurately quantify the ... only limited information regarding the success of this radiotherapy treatment ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
Breaking Medicine Technology:
(Date:7/24/2017)... Lewisville, TX (PRWEB) , ... July 24, 2017 ... ... grants under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State ... State of California Department of Health Care Services, will facilitate the development of ...
(Date:7/24/2017)... ... 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, announced ... and divided between two full-time university students enrolled in U.S. or Canadian accredited ... apply for the scholarship, students are asked to submit an essay between 750 ...
(Date:7/24/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... to expand its solution to help government contractors more quickly and cost-effectively comply ... to address the authentication requirements within NIST SP800-171, but no matter how you ...
(Date:7/24/2017)... ... ... people are taking more steps to protect themselves from sunburn, half of all adults and ... the past year. It’s common and people have been dealing with them since the dawn ... conscientious of the risks that accompany sunburns. , The team at AloeVera.com , a ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... August 13-17 in National Harbor, MD. This year's theme focuses on the new ... principal benchmarks for quality and integrity in testing and calibration will be changed. ...
Breaking Medicine News(10 mins):